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INTRODUCTION
Turner syndrome (TS) is the most common chromosomal 
abnormality in females, affecting 1 : 2,500 live female births, 
and is a condition involving total or partial absence of one X 
chromosome in all or part of the cells, reduced final height, 
absence of female sex hormones, and in most cases infertility 
[1]. Some cancer types, such as colon cancer, thyroid carci-
noma, and acute myeloid leukemia were reported in patients 
with TS [1-3]. Two types of gynecologic tumors are commonly 
described in TS, the first one is gonadoblastoma, which occurs 
in patients with Y chromosome abnormalities, and the second 
one is endometrial carcinoma which is mo  stly related with ex-
ogenous estrogen usage [1,4]. Here, we describe an extremely 
rare case of squamous cell carcinoma of the vulva (SCCV) in a 
young virgin woman with Turner syn  drome.
CASE REPORT
A 35-years old single, virgin woman referred to our Oncology 
Department with wart like, necrotized, exophytic vulvar mass. 
The size of the lesion was around 6-7 cm. It was originated 
from the left labia majora and extended to the clitoris and 
urethral meatus. There was a suspicious palpable right groin 
lymph node. Biopsy specimen of the vulvar mass revealed SCCV 
(well-differentiated). 
Case Report












3Genetics, Dr. Zekai Tahir Burak Women’s Health Education and Research 
Hospital, Ankara, Turkey
Received Aug 15, 2010, Accepted Oct 6, 2010
Correspondence to Omer Lutfi Tapisiz
Department of Gynecologic Oncology, Dr. Zekai Tahir Burak Women’s 
Health Education and Research Hospital, Turan Gunes Bulvari, Sedir Sitesi, 




Copyright © 2011. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology and Colposcopy 
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License 
(http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and 
reproduction in any medium, provided the original work is properly cited.
www.ejgo.org
Two types of gynecologic tumors are commonly described in the Turner syndrome, the first one is gonadoblastoma, which 
occurs in patients with Y chromosome abnormalities, and the second one is endometrial carcinoma which is mostly related with 
exogenous estrogen usage. Here, we describe an extremely rare case of squamous cell carcinoma of the vulva in a virgin woman 
with Turner syndrome. A 35-years old single, virgin woman referred to our Oncology Department with warty, necrotized, exo-
phy  tic 6-7 cm vulvar mass. She had a history of primary amenorrhea and mosaic Turner syndrome was determined in her karyo  type 
analysis. Biopsy specimen of the vulvar mass revealed squamous cell carcinoma of the vulva, and total vulvectomy with inguinal 
femoral lymphadenectomy was performed. The postoperative course was uneventful and there has been no recurrence of the 
disease up to date. Women with Turner syndrome have streak ovaries that produce very low estrogen and the squamous cell 
carcinoma of the vulva may have developed at an early age with Turner syndrome because of this low estrogen value similar to 
postmenopausal women. The current case is a special case due to its age of occurrence, virgin and Turner syndrome status.
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She had a history of primary amenorrhea, and the clinical 
dia  gnosis of TS before but she did not have the medical re-
ports proving TS. Therefore, karyotype analysis was performed 
in our hospital’s Genetic Department by the con  ven  tional G-
banding method using peripheral blood lymp  h  ocytes. Mosaic 
TS was de  termined in her karyotype analy  sis. According to her 
his  to  ry, she had no sexual relation  ship of any kind. She had re-
cei  v  e  d estrogen replace  ment therapy for only 6 months, and 
she had no histo  ry of tobacco use. Her family history was un-
remarkable. The serum hormonal assay revealed, FSH, 64.86 
mIU/mL; LH, 38.45 mIU/mL; progesterone, 0.38 pg/mL; and 
estra  diol, 14.54 pg/mL, all of the other laboratory results were 
normal. 
Total vulvectomy with inguinal femoral lymphadenectomy 
was performed. The final histological diagnosis was SCCV (Fig. 
1), and vascular or neuronal invasion was not observed. The 
surgical margins were free of disease. The inguinal and femo-
ral lymph nodes were negative. The clinicopathologic stage 
(FIGO) was stage II. The postoperative course was un  eventful 
and there has been no recurrence of the disease up to date.
DISCUSSION
Cancer of the vulva which is primarily a disease of postmeno-
pausal women, with a peak incidence in the late 60’s is res-
ponsible for approximately 3-5% of gynecologic cancers. 
SCCV is the most common type among the vulvar cancers. 
This disease typically develops in older women (in their sev-
enth or eighth decade of life) and is rarely seen in women 
younger than 35 years of age [5]. The current case is a special 
case due to its age of occurrence, virgin and TS status. To our 
knowledge, there are no published reports of SCCV in a young 
virgin woman with TS.
The etiology of SCCV is not well known and epidemiological 
evidence to date suggests that there are two etiologic path-
ways responsible in carcinogenesis [6,7]. The first one is often 
seen in older women and related with non-neoplastic epi-
thelial dis  orders, mainly atrophic dystrophy which is seen in 
low estro  gen states. The second one is often seen in younger 
women and is associated with human papillomavirus (HPV) 
infection [8]. The study performed by Jones et al. su  gge  sted an 
increa  sing incidence of vulvar intraepithelial neopla  sm related 
with HPV in women younger than 50 years of age [9]. Another 
study reported by Huang et al. [10] showed the importance of 
HPV integration in both cervical and vulvar cancers. How  ever; 
both of the etiologic paths were not appropriate for explain-
ing the mechanism of the disease in our young and virgin 
case. Other risk factors include current tobacco use, the pres-
ence of genital warts, and multiple sexual partners [7,8], but 
these were also not present in our case. 
In the English literature, we found only one case that presented 
with vulvar carcinoma in a TS patient. In this report Iwamoto 
et al. [11] concluded that the vulvar carcinoma may be related 
with low estrogen levels in TS like in elderly postmenopausal 
women. In our opinion this etiologic path may explain our cases’ 
condition.
In conclusion, women with TS have streak ovaries that pro-
duce very low estrogen and SCCV may have developed at an 
early age with TS because of this low estrogen value similar to 
postmenopausal women. Here, we described the first case of 
SCCV in a young virgin patient with TS.
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